Cargando…
Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix
Since 2014, the World Health Organization (WHO) member states have been annually reporting vaccine hesitancy reasons, using the WHO/UNICEF Joint Reporting Form (JRF). The Vaccine Hesitancy Matrix (VHM), developed by a WHO strategic advisory group of experts, can serve as an important tool to categor...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189077/ https://www.ncbi.nlm.nih.gov/pubmed/33534626 http://dx.doi.org/10.1080/21645515.2020.1859319 |
_version_ | 1783705443780001792 |
---|---|
author | Kulkarni, Shibani Harvey, Bonnie Prybylski, Dimitri Jalloh, Mohamed F. |
author_facet | Kulkarni, Shibani Harvey, Bonnie Prybylski, Dimitri Jalloh, Mohamed F. |
author_sort | Kulkarni, Shibani |
collection | PubMed |
description | Since 2014, the World Health Organization (WHO) member states have been annually reporting vaccine hesitancy reasons, using the WHO/UNICEF Joint Reporting Form (JRF). The Vaccine Hesitancy Matrix (VHM), developed by a WHO strategic advisory group of experts, can serve as an important tool to categorize vaccine hesitancy reasons reported in the JRF. We aimed to describe the reasons for vaccine hesitancy reported globally from 2014 to 2017 to ascertain trends over time and understand the comparability of using the VHM to classify hesitancy reasons from 2014 to 2016 based on previously published literature. We conducted a quantitative content analysis to code and categorize vaccine hesitancy reasons reported in the JRF from 2014 to 2017. Vaccine hesitancy trends were consistent from 2014 to 2017, where vaccine hesitancy reasons were mainly related to “individual and group level influences” (59%) followed by “contextual influences” (25%), and “vaccine- or vaccination-specific issues” (16%). Comparability of our approach to categorize vaccine hesitancy to the previously published JRF data showed that results were mostly but not entirely consistent. Major differences in categorizing vaccine hesitancy were noted between two specific reasons – “experience with past vaccination” (under “individual and group influences”) and “risk/benefit- scientific evidence” (under “vaccine and vaccination-specific issues”); this was usually due to lack of clear definitions in some sub-categories and generic responses reported in the JRF. The JRF hesitancy module may benefit from modifications to improve the data quality. Understanding global vaccine hesitancy is crucial and JRF can serve as an important tool, especially with the potential introduction of a COVID-19 vaccine. |
format | Online Article Text |
id | pubmed-8189077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-81890772021-06-17 Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix Kulkarni, Shibani Harvey, Bonnie Prybylski, Dimitri Jalloh, Mohamed F. Hum Vaccin Immunother Research Paper Since 2014, the World Health Organization (WHO) member states have been annually reporting vaccine hesitancy reasons, using the WHO/UNICEF Joint Reporting Form (JRF). The Vaccine Hesitancy Matrix (VHM), developed by a WHO strategic advisory group of experts, can serve as an important tool to categorize vaccine hesitancy reasons reported in the JRF. We aimed to describe the reasons for vaccine hesitancy reported globally from 2014 to 2017 to ascertain trends over time and understand the comparability of using the VHM to classify hesitancy reasons from 2014 to 2016 based on previously published literature. We conducted a quantitative content analysis to code and categorize vaccine hesitancy reasons reported in the JRF from 2014 to 2017. Vaccine hesitancy trends were consistent from 2014 to 2017, where vaccine hesitancy reasons were mainly related to “individual and group level influences” (59%) followed by “contextual influences” (25%), and “vaccine- or vaccination-specific issues” (16%). Comparability of our approach to categorize vaccine hesitancy to the previously published JRF data showed that results were mostly but not entirely consistent. Major differences in categorizing vaccine hesitancy were noted between two specific reasons – “experience with past vaccination” (under “individual and group influences”) and “risk/benefit- scientific evidence” (under “vaccine and vaccination-specific issues”); this was usually due to lack of clear definitions in some sub-categories and generic responses reported in the JRF. The JRF hesitancy module may benefit from modifications to improve the data quality. Understanding global vaccine hesitancy is crucial and JRF can serve as an important tool, especially with the potential introduction of a COVID-19 vaccine. Taylor & Francis 2021-02-03 /pmc/articles/PMC8189077/ /pubmed/33534626 http://dx.doi.org/10.1080/21645515.2020.1859319 Text en This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 USC. 105, no copyright protection is available for such works under US Law. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Paper Kulkarni, Shibani Harvey, Bonnie Prybylski, Dimitri Jalloh, Mohamed F. Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title | Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title_full | Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title_fullStr | Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title_full_unstemmed | Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title_short | Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014–2017: Use and comparability of the Vaccine Hesitancy Matrix |
title_sort | trends in classifying vaccine hesitancy reasons reported in the who/unicef joint reporting form, 2014–2017: use and comparability of the vaccine hesitancy matrix |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189077/ https://www.ncbi.nlm.nih.gov/pubmed/33534626 http://dx.doi.org/10.1080/21645515.2020.1859319 |
work_keys_str_mv | AT kulkarnishibani trendsinclassifyingvaccinehesitancyreasonsreportedinthewhounicefjointreportingform20142017useandcomparabilityofthevaccinehesitancymatrix AT harveybonnie trendsinclassifyingvaccinehesitancyreasonsreportedinthewhounicefjointreportingform20142017useandcomparabilityofthevaccinehesitancymatrix AT prybylskidimitri trendsinclassifyingvaccinehesitancyreasonsreportedinthewhounicefjointreportingform20142017useandcomparabilityofthevaccinehesitancymatrix AT jallohmohamedf trendsinclassifyingvaccinehesitancyreasonsreportedinthewhounicefjointreportingform20142017useandcomparabilityofthevaccinehesitancymatrix |